1177:HKG
Sino Biopharmaceutical Ltd
5,68Â HK$
arrow_upward
+1,61%(+0,090) 1 p
24. apr, 16:08:25 GMT +8 · HKD
search
Kõik sĂ¼mbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| SĂ¼mbol | Hind | Muutus | % muutus |
|---|
insights_autoĂœksuse 1177 põhistatistika genereerimine…
Ava
5,55Â HK$
Kõrge
5,69Â HK$
Madal
5,47Â HK$
Turu kapit.
106,47Â mld
Keskm. maht
74,85Â mln
Maht
83,66Â mln
Dividend
1,76%
Kvartaalne dividend
0,03Â HK$
Dividendikuupäev
29. aug 2025
Hinna ja tulu suhe
38,12
52 näd kõrgeim
9,12Â HK$
52 näd madalaim
3,74Â HK$
Aktsiatulu
0,15Â HK$
Käibivad aktsiad
12,64Â mld
Töötajate arv
21Â tuh
Uudised
Erinevatest veebiallikatest
TipRanks
·
3 päeva eest
Sino Biopharm Unit LaNova Unveils Promising ADC Data at AACR 2026
Profiil
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
Teave Ă¼ksuse Sino Biopharmaceutical Ltd kohta
AI genereeritud sisu võib sisaldada vigu. Lisateave